n.a. (SNTS)

Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Shares Outstanding 67.14M
Div & Yield N.A. (N.A)
Friday's Health Winners & Losers

Friday's Health Winners & Losers

Tercica climbs after swinging to a quarterly profit.

Friday's Health Winners & Losers

Neurogen rises on a new CEO appointment.

Santarus Sues Par Pharma

The lawsuit is filed in response to Par's pursuit of a generic version of heartburn drug Zegerid.

Monday's Small-Cap Winners & Losers

GigaBeam shines on a WiFiber deal.

Santarus Posts Narrower Loss

Acid reflux treatment Zegerid boosts second-quarter results, but the company pulls 2008 sales guidance.

Santarus Climbs on Promo Deal

The drug company will co-promote Victory Pharma's Naprelan.

Tuesday's Early Winners & Losers

InterMune collapses after halting a late-stage study of Actimmune.

Cramer's 'Mad Money' Recap: The Knot Worth Tying

Cramer believes Yahoo! should buy The Knot, but the wedding site's headed higher even if the two don't get hitched. Plus, Google $560 or bust.

Early Christmas for Santarus

Shares rise on a licensing deal.

Not Sounding the All-Clear Yet

The market environment remains dangerous at this juncture.

Today's Health Winners and Losers

DexCom shares jump after the FDA approves its glucose monitoring system.

Cramer's 'Mad Money' Recap: Diabetic Stock

As more people get diagnosed with diabetes, DexCom's new glucose monitoring device could be huge, says Cramer.

Health Stocks in Motion

Idenix Pharmaceuticals jumps after reporting positive data for a hepatitis C treatment.

Health Stocks in Motion

Santarus rises on stock financing.

Health Stocks in Motion

Health Stocks in Motion

Inhibitex falls after posting a fourth-quarter loss.